Shionogi & Co., Ltd. (SGIOY)
- 2021-04-20 15:59:20
- POST
- Other OTC
- Delayed Quote
- USD
Last
12.76 -0.27 (-2.07%)Volume
322,57552 Week Range
12.26 - 14.94
Key Stats
Ratios/Profitability
Events
Technical Indicators (Daily)
About
Shionogi & Company, Limited is a Japanese pharmaceutical company best known for developing Crestor. Medical supply and brand name also uses Shionogi. Shionogi has business roots that date back to 1878, and was incorporated in 1919. Among the medicines produced are for hyperlipidaemia, antibiotics, and cancer medicines. In Japan it is particularly known as a producer of antimicrobial and antibiotics.
Latest News
Japan, eyeing Olympics, lines up half-billion doses of COVID-19 vaccine
Japan is making an aggressive move to grab enough coronavirus vaccine to inoculate its population four times over, a push the government hopes will instil confidence that it can host a delayed summer ...
CORRECTED-(OFFICIAL)-GSK says long-acting HIV prevention drug 66% more effective than Truvada
Britain's GSK said on Tuesday that an injection of its cabotegravir drug given every two months was found to be 66% more effective in preventing HIV infections than Gilead's Truvada daily oral pills. ...
U.S. FDA approves GSK unit's drug to treat infants and children with HIV
The U.S. Food and Drug Administration has approved a drug to treat infants and children with HIV, with the drug having been developed by drugmaker GlaxoSmithKline's HIV drugs division ViiV Healthcare,...
Japan's AnGes speeds towards 2021 rollout in coronavirus 'vaccine war'
Japanese biotech AnGes Inc expects its coronavirus vaccine to be ready as early as the first half of 2021, if it can overcome supply chain and production hurdles, the company's founder said. The Osaka...
Latest Comments
Related Stocks
Disclaimer: The data contained in Super Surge website is not necessarily real-time nor accurate and may differ from the actual market data. Prices, volumes, ratios, charts and indicators are indicative and not appropriate for trading purposes. Super Surge doesn't bear any responsibility for any trading losses you might incur as a result of using this data.